Fortune Magazine names Cerner to its 2015 Most Admired Companies list.
Castlight Health announces Q4 and 2014 year end results: Revenue for 2014 closed out at $45.6 million, a 252 percent increase over 2013, but still resulting in an overall $86.2 million operating loss, EPS -$1.16 vs. -$6.28. Stock prices dropped 31 percent Thursday following an analyst’s downgrade.
Oregon has filed another lawsuit against Oracle, seeking to bar the company from doing business in the state, over claims that Oracle is preparing to pull the plug on hosting Oregon’s state insurance exchange.
After a long regulatory battle with the FDA, genetic testing service provider 23andMe earns regulatory approval to market its personal genome testing service. The company is only approved to test for a genetic mutation associated with Bloom syndrome, a rare disorder that leads to an increased risk of cancer.